Summary
Portola Merck deal is the indication of way things are currently in Global Pharma Industry. Big Pharma have virtually stopped innovating, and even if they do their costs are not sustainable. Portola and companies like Portola are the future of pharma innovation. Its going to be a case of "Tail wagging the Dog" undefined
Analysis
Oral Factor Xa inhibitor anticoagulant being developed by Portola is going to be replacing Warfarin a drug which is 60 - 70 years old.
When it becomes available there is going to be very less resistance and very less competition.
Merck has spotted this opportunity, in today day and age of week / month upgrades from Tech firms, here we will be having and upgrade after nearly 60 years.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
